- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04101188
Mechanisms Underlying the Protective Vascular Effects of Dietary Potassium in Humans
May 30, 2023 updated by: University of Delaware
Americans continue to consume high amounts of sodium.
Potassium is notable for its blood pressure lowering effects but less is known regarding its effect on the vasculature.
This investigation seeks to determine the role of dietary potassium on the vasculature in the presence of a high sodium diet in salt-resistant adults.
Study Overview
Status
Recruiting
Conditions
Detailed Description
Significant public health efforts have been made towards salt reduction but most have met with failure.
Dietary factors such high sodium/low potassium diets contribute to the development of cardiovascular diseases (CVDs) such as atherosclerosis and high blood pressure (BP).
This is important as CVD is the number one killer in the U.S.
While the role of these two nutrients on BP is widely accepted, their impact on the vasculature has received less attention.
Endothelial dysfunction, characterized by impaired dilation, is an important non-traditional risk factor for atherosclerosis.
Evidence supporting potassium's beneficial role on vascular health remains unclear although it may be more effective in the presence of a high sodium diet.
A purported mechanism responsible for sodium-induced vascular dysfunction is overproduction of reactive oxygen species (ROS) resulting in reduced nitric oxide (NO) production/bioavailability.
Additionally, high sodium diets have been shown to stiffen the endothelium.
This investigation will evaluate the vascular effects of dietary potassium during a high salt diet including its impact on sodium-induced oxidative stress and endothelial cell stiffness.
Study Type
Interventional
Enrollment (Estimated)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Liza J Walker, BS
- Phone Number: (302)831-3181
- Email: lizaj@udel.edu
Study Contact Backup
- Name: Shannon L Lennon, PhD
- Phone Number: 3028312798
- Email: slennon@udel.edu
Study Locations
-
-
Delaware
-
Newark, Delaware, United States, 19716
- Recruiting
- University of Delaware
-
Contact:
- Liza Walker, BS
- Phone Number: 302-831-3181
- Email: lizaj@udel.edu
-
Contact:
- Shannon L Lennon, PhD
- Phone Number: 3028312798
- Email: slennon@udel.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- healthy
- normal blood pressure
- normal resting ECG
Exclusion Criteria:
- hypertension
- history of heart disease
- diabetes
- kidney disease
- obese (BMI ≥30)
- significant weight changes in the last 6 months
- use of tobacco products
- pregnant
- on a special diet (gluten free; vegan)
- take any medications for the above conditions
- endurance trained athletes
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Moderate Potassium/Low Sodium
Subjects will be provided with a diet that is moderate in potassium and low in sodium.
|
Consumption of 10 days of a diet moderate in potassium and low in sodium.
|
Experimental: Moderate Potassium/High Sodium
Subjects will be provided with a diet that is moderate in potassium and high in sodium.
|
Consumption of 10 days of a diet moderate in potassium and high in sodium.
|
Experimental: High Potassium/High Sodium
Subjects will be provided with a diet that is high in both potassium and sodium.
|
Consumption of 10 days of a diet high in potassium and high in sodium.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Conduit artery endothelial-dependent dilation
Time Frame: on day 10 of the diet
|
The change in flow-mediated dilation (FMD) between the 3 diets as assessed by brachial artery FMD
|
on day 10 of the diet
|
Microvascular function
Time Frame: on day 10 of the diet
|
Cutaneous microvascular dilatory response to local heating assessed by laser Doppler flowmetry coupled with intradermal microdialysis
|
on day 10 of the diet
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Ambulatory BP monitoring
Time Frame: on day 7 and 10 of diet
|
assessed by 24-hour ambulatory blood pressure
|
on day 7 and 10 of diet
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Shannon L Lennon, PhD, University of Delaware
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 16, 2020
Primary Completion (Estimated)
August 30, 2024
Study Completion (Estimated)
December 31, 2024
Study Registration Dates
First Submitted
September 23, 2019
First Submitted That Met QC Criteria
September 23, 2019
First Posted (Actual)
September 24, 2019
Study Record Updates
Last Update Posted (Actual)
June 1, 2023
Last Update Submitted That Met QC Criteria
May 30, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 1472577
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Risk Factor
-
University of Southern DenmarkRegion of Southern Denmark; Odense Patient Data Explorative Network; ENIGMA Solutions... and other collaboratorsActive, not recruitingCardiovascular Risk Factor | Risk CommunicationDenmark
-
University of Split, School of MedicineCompletedCardiovascular Risk Factor | Lifestyle Risk ReductionCroatia
-
University Hospital, BrestRecruiting
-
University Hospitals Cleveland Medical CenterRecruitingCardiovascular Risk FactorUnited States
-
Northwestern UniversityNorthShore University HealthSystem; Case Western Reserve University; Shirley... and other collaboratorsCompleted
-
University of ArizonaTerminatedCardiovascular Risk FactorUnited States
-
Penn State UniversityCompletedCardiovascular Risk FactorUnited States
-
Clinique BizetCompleted
-
University Hospital, BrestCompleted
-
University of DelawareCompleted
Clinical Trials on Moderate Potassium/Low Sodium Diet
-
University of DelawareCompleted
-
National Heart, Lung, and Blood Institute (NHLBI)Completed
-
Zhejiang UniversityNational Natural Science Foundation of China; Chinese PLA General Hospital; National...Completed
-
Brigham and Women's HospitalBoston Children's Hospital; Boston Medical Center; Nutrition Science Initiative; New Balance Foundation and other collaboratorsCompleted
-
Burke Rehabilitation HospitalCompletedStroke | Ischemic StrokeUnited States
-
Sahlgrenska University Hospital, SwedenCompletedIrritable Bowel SyndromeSweden
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Ospedali Riuniti di FoggiaCompleted
-
Penn State UniversityNational Cattlemen's Beef AssociationCompletedCardiovascular Disease | Metabolic SyndromeUnited States
-
Duke UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Vascular Diseases | Hypertension | Obesity